Double transfection improves small interfering RNA-induced thrombin receptor (PAR-1) gene silencing in du 145 prostate cancer cells

FEBS Letters

Volumn 577, Issue 1-2, 2004, Pages 175-180

  Liu, Jian ^a   Schuff Werner, Peter ^a   Steiner, Michael ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Double transfection; dsRNA, double stranded RNA; ECM, extracellular matrix; FN, fibronectin; LN, laminin; PAR 1; PAR 1, protease activated receptor 1; RNA interference; RNAi, RNA interference; siRNA, small interfering RNA; Small interfering RNA; Thrombin

Indexed keywords

FIBRONECTIN; LAMININ; MESSENGER RNA; PROTEINASE ACTIVATED RECEPTOR 1; RECEPTOR PROTEIN; SCLEROPROTEIN; SMALL INTERFERING RNA; THROMBIN;

ARTICLE; CANCER CELL; CANCER GENETICS; CELL ADHESION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KNOCKOUT GENE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE;

BASE SEQUENCE; CELL ADHESION; CELL LINE, TUMOR; DNA PRIMERS; FLOW CYTOMETRY; GENE SILENCING; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTOR, PAR-1; RNA, SMALL INTERFERING; TRANSFECTION;

RICKETTSIA SP. PAR;

EID: 7544240162     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.09.079     Document Type: Article

References (26)

1. Elbashir S.M., Harborth J., Weber K., Tuschl T. Methods. 26:2002;199-213
2. Dorsett Y., Tuschl T. Nat. Rev. Drug Discov. 3:2004;318-329
3. Hasuwa H., Kaseda K., Einarsdottir T., Okabe M. FEBS Lett. 532:2002;227-230
4. Downward J. BMJ. 328:2004;1245-1248
5. Liu J., Schuff-Werner P., Steiner M. Biomed. Rev. 14:2003;9-22
6. Ossovskaya V.S., Bunnett N.W. Physiol. Rev. 84:2004;579-621
7. Kaufmann R., Schafberg H., Rudroff C., Nowak G. Cancer. 80:1997;2068-2074
8. Rudroff C., Striegler S., Schilli M., Scheele J. Eur. J. Surg. Oncol. 27:2001;472-476
9. Huang Y.Q., Li J.J., Hu L., Lee M., Karpatkin S. Thromb. Haemost. 86:2001;1094-1098
10. Ahmad R., Knafo L., Xu J., Sindhu S.T., Menezes J., Ahmad A. Int. J. Cancer. 87:2000;707-715
11. Tran T., Stewart A.G. Br. J. Pharmacol. 138:2003;865-875
12. Chay C.H., Cooper C.R., Gendernalik J.D., Dhanasekaran S.M., Chinnaiyan A.M., Rubin M.A., Schmaier A.H., Pienta K.J. Urology. 60:2002;760-765
13. Liu J., Bastian M., Kohlschein P., Schuff-Werner P., Steiner M. Urol. Res. 31:2003;163-168
14. Greenberg D.L., Mize G.J., Takayama T.K. Biochemistry. 42:2003;702-709
15. Amarzguioui M. Biotechniques. 36:2004;766-768
16. Darmoul D., Marie J.C., Devaud H., Gratio V., Laburthe M. Br. J. Cancer. 85:2001;772-779
17. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Nature. 411:2001;494-498
18. Holen T., Amarzguioui M., Wiiger M.T., Babaie E., Prydz H. Nucleic Acids Res. 30:2002;1757-1766
19. Ji J., Wernli M., Klimkait T., Erb P. FEBS Lett. 552:2003;247-252
20. Muratovska A., Eccles M.R. FEBS Lett. 558:2004;63-68
21. Hohjoh H. FEBS Lett. 557:2004;193-198
22. Scherr M., Morgan M.A., Eder M. Curr. Med. Chem. 10:2003;245-256
23. Yang S., Tutton S., Pierce E., Yoon K. Mol. Cell Biol. 21:2001;7807-7816
24. Nierodzik M.L., Klepfish A., Karpatkin S. Thromb. Haemost. 74:1995;282-290
25. Wojtukiewicz M.Z., Tang D.G., Ben-Josef E., Renaud C., Walz D.A., Honn K.V. Cancer Res. 55:1995;698-704
26. Nierodzik M.L., Chen K., Takeshita K., Li J.J., Huang Y.Q., Feng X.S., D'Andrea M.R., Andrade-Gordon P., Karpatkin S. Blood. 92:1998;3694-3700